Remission & chronicity

Spontaneous remission

Spontaneous clearance in <30% of acute cases; chronic infection rarely clears without treatment (<1%/year)

Best-intervention remission

>95% cured (sustained virologic response at 12 weeks) with 8-12 week courses of direct-acting antivirals (DAAs)

Gap size

Near-zero biological gap; large access/utilization gap

Primary barrier

access

Only 65% of eligible patients with private insurance received DAA treatment as of 2020; rates declining since 2019; Medicaid restrictions remain in many states; $20,000+ drug cost for generics unavailable in US

Biomarker Targets & Therapeutic Agents

Gene targets queried against DGIdb, Open Targets, ChEMBL, PubMed, and Europe PMC. Agents ranked: ● Clinical > ● Mechanistic > ● Correlative.

DDX58 1 HAVCR2 78 IFIT1 2 IFNAR1 19 IFNL3 25 IFNL4 15 IRF3 2 IRF9 0 MAVS 2 MX1 0 OAS1 3 PDCD1 44 STAT1 6 TGFB1 62 TLR3 18

DDX58

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Potency	Source
INARIGIVIR SOPROXIL	? unclear	Mechanistic		DGIdb

HAVCR2

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Potency	Source
SABATOLIMAB	↓ inhibits	Mechanistic		DGIdb
ANTI-TIM-3 MONOCLONAL ANTIBODY	? unclear	Mechanistic		DGIdb
PD1 INHIBITOR	? unclear	Mechanistic		DGIdb
ANTI-TIM3 MONOCLONAL ANTIBODY LY3321367	? unclear	Mechanistic		DGIdb
LOMVASTOMIG	↓ inhibits	Mechanistic		DGIdb
COBOLIMAB	↓ inhibits	Mechanistic		DGIdb
CHEMBL1569082	↓ inhibits	Mechanistic	810000.0 nM (Kd)	ChEMBL
CHEMBL4876694	↓ inhibits	Mechanistic	330000.0 nM (Kd)	ChEMBL
CHEMBL4866110	↓ inhibits	Mechanistic	250000.0 nM (Kd)	ChEMBL
CHEMBL4860123	↓ inhibits	Mechanistic	40000.0 nM (Kd)	ChEMBL
CHEMBL4870128	↓ inhibits	Mechanistic	40000.0 nM (Kd)	ChEMBL
CHEMBL4852144	↓ inhibits	Mechanistic	50000.0 nM (Kd)	ChEMBL
CHEMBL4864057	↓ inhibits	Mechanistic	90000.0 nM (Kd)	ChEMBL
CHEMBL4871549	↓ inhibits	Mechanistic	90000.0 nM (Kd)	ChEMBL
CHEMBL4870200	↓ inhibits	Mechanistic	40000.0 nM (Kd)	ChEMBL
CHEMBL4854696	↓ inhibits	Mechanistic	40000.0 nM (Kd)	ChEMBL
CHEMBL4863477	↓ inhibits	Mechanistic	10000.0 nM (Kd)	ChEMBL
CHEMBL4865760	↓ inhibits	Mechanistic	130000.0 nM (Kd)	ChEMBL
CHEMBL4876887	↓ inhibits	Mechanistic	450000.0 nM (Kd)	ChEMBL
CHEMBL1610810	↓ inhibits	Mechanistic	460000.0 nM (Kd)	ChEMBL
CHEMBL1462057	↓ inhibits	Mechanistic	530000.0 nM (Kd)	ChEMBL
CHEMBL4854485	↓ inhibits	Mechanistic	740000.0 nM (Kd)	ChEMBL
CHEMBL69086	↓ inhibits	Mechanistic	670000.0 nM (Kd)	ChEMBL
CHEMBL4864031	↓ inhibits	Mechanistic	780000.0 nM (Kd)	ChEMBL
CHEMBL2132792	↓ inhibits	Mechanistic	1400000.0 nM (Kd)	ChEMBL
CHEMBL1576751	↓ inhibits	Mechanistic	850000.0 nM (Kd)	ChEMBL
CHEMBL4848599	↓ inhibits	Mechanistic	2000.0 nM (Kd)	ChEMBL
CHEMBL4873902	↓ inhibits	Mechanistic	250.0 nM (Kd)	ChEMBL
CHEMBL4859588	↓ inhibits	Mechanistic	1600.0 nM (Ki)	ChEMBL
CHEMBL4860976	↓ inhibits	Mechanistic	2100.0 nM (Ki)	ChEMBL
CHEMBL4874818	↓ inhibits	Mechanistic	1500.0 nM (Ki)	ChEMBL
CHEMBL4851756	↓ inhibits	Mechanistic	1800.0 nM (Ki)	ChEMBL
CHEMBL4872496	↓ inhibits	Mechanistic	2200.0 nM (Ki)	ChEMBL
CHEMBL4876721	↓ inhibits	Mechanistic	2300.0 nM (Ki)	ChEMBL
CHEMBL4864303	↓ inhibits	Mechanistic	2600.0 nM (Ki)	ChEMBL
CHEMBL4846039	↓ inhibits	Mechanistic	1500.0 nM (Ki)	ChEMBL
CHEMBL4875904	↓ inhibits	Mechanistic	1300.0 nM (Ki)	ChEMBL
CHEMBL4868118	↓ inhibits	Mechanistic	970.0 nM (Ki)	ChEMBL
CHEMBL4873816	↓ inhibits	Mechanistic	550.0 nM (Ki)	ChEMBL
CHEMBL4863017	↓ inhibits	Mechanistic	750.0 nM (Ki)	ChEMBL

Showing top 40 of 78 agents ranked by evidence tier.

IFIT1

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Potency	Source
PEGINTERFERON ALFA-2B	? unclear	Mechanistic		DGIdb
RIBAVIRIN	? unclear	Mechanistic		DGIdb

IFNAR1

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Potency	Source
INTERFERON ALFACON-1	↑ activates	Mechanistic		DGIdb
INTERFERON BETA	? unclear	Mechanistic		DGIdb
PEGINTERFERON ALFA-2A	↑ activates	Mechanistic		DGIdb
INTERFERON BETA-1B	↑ activates	Mechanistic		DGIdb
PEGINTERFERON BETA-1A	↑ activates	Mechanistic		DGIdb
ALBINTERFERON ALFA-2B	↑ activates	Mechanistic		DGIdb
ROPEGINTERFERON ALFA-2B	~ modulates	Mechanistic		DGIdb
INTERFERON ALFA	? unclear	Mechanistic		DGIdb
INTERFERON ALFA-2B	↑ activates	Mechanistic		DGIdb
GLATIRAMER	? unclear	Mechanistic		DGIdb
INTERFERON ALFA-N1	? unclear	Mechanistic		DGIdb
INTERFERON BETA-1A	↑ activates	Mechanistic		DGIdb
PEGINTERFERON ALFACON-1	? unclear	Mechanistic		DGIdb
ANIFROLUMAB	↓ inhibits	Mechanistic		DGIdb
PEGINTERFERON ALFA-2B	↑ activates	Mechanistic		DGIdb
INTERFERON ALFA-N3	↑ activates	Mechanistic		DGIdb
SIFALIMUMAB	? unclear	Mechanistic		DGIdb
INTERFERON ALFA-2A	? unclear	Mechanistic		Open Targets
CHEMBL1617534	↓ inhibits	Mechanistic	4000.0 nM (Kd)	ChEMBL

IFNL3

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Source
ASUNAPREVIR	? unclear	Mechanistic	DGIdb
VOXILAPREVIR	? unclear	Mechanistic	DGIdb
PARITAPREVIR	? unclear	Mechanistic	DGIdb
SIMEPREVIR	? unclear	Mechanistic	DGIdb
OMBITASVIR	? unclear	Mechanistic	DGIdb
INTERFERON ALFA-N1	? unclear	Mechanistic	DGIdb
ELBASVIR/GRAZOPREVIR	? unclear	Mechanistic	DGIdb
SOFOSBUVIR	? unclear	Mechanistic	DGIdb
LEDIPASVIR	? unclear	Mechanistic	DGIdb
DELEOBUVIR	? unclear	Mechanistic	DGIdb
PEGINTERFERON ALFA-2B	? unclear	Mechanistic	DGIdb
DASABUVIR	? unclear	Mechanistic	DGIdb
DACLATASVIR	? unclear	Mechanistic	DGIdb
ELBASVIR	? unclear	Mechanistic	DGIdb
PEGINTERFERON ALFA-2A	? unclear	Mechanistic	DGIdb
RITONAVIR	? unclear	Mechanistic	DGIdb
SOFOSBUVIR / VELPATASVIR / VOXILAPREVIR	? unclear	Mechanistic	DGIdb
GRAZOPREVIR	? unclear	Mechanistic	DGIdb
FALDAPREVIR	? unclear	Mechanistic	DGIdb
VELPATASVIR	? unclear	Mechanistic	DGIdb
TELAPREVIR	? unclear	Mechanistic	DGIdb
OMBITASVIR/PARITAPREVIR/RITONAVIR	? unclear	Mechanistic	DGIdb
SOFOSBUVIR/VELPATASVIR	? unclear	Mechanistic	DGIdb
ATORVASTATIN CALCIUM TRIHYDRATE	? unclear	Mechanistic	DGIdb
BOCEPREVIR	? unclear	Mechanistic	DGIdb

IFNL4

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Source
LEDIPASVIR	? unclear	Mechanistic	DGIdb
INTERFERON ALFA-N1	? unclear	Mechanistic	DGIdb
FALDAPREVIR	? unclear	Mechanistic	DGIdb
VELPATASVIR	? unclear	Mechanistic	DGIdb
DELEOBUVIR	? unclear	Mechanistic	DGIdb
INTERFERON ALFA-2B	? unclear	Mechanistic	DGIdb
OMBITASVIR/PARITAPREVIR/RITONAVIR	? unclear	Mechanistic	DGIdb
ASUNAPREVIR	? unclear	Mechanistic	DGIdb
BOCEPREVIR	? unclear	Mechanistic	DGIdb
PEGINTERFERON ALFA-2A	? unclear	Mechanistic	DGIdb
DACLATASVIR	? unclear	Mechanistic	DGIdb
ATORVASTATIN CALCIUM TRIHYDRATE	? unclear	Mechanistic	DGIdb
SIMEPREVIR	? unclear	Mechanistic	DGIdb
VOXILAPREVIR	? unclear	Mechanistic	DGIdb
ELBASVIR/GRAZOPREVIR	? unclear	Mechanistic	DGIdb

IRF3

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Potency	Source
RECOMBINANT INTERFERON	? unclear	Mechanistic		DGIdb
CHEMBL4471585	↑ activates	Mechanistic	27600.0 nM (EC50)	ChEMBL

IRF9

UniProt Ensembl DGIdb Open Targets

Pipeline results not yet available for this target. Run the pipeline to populate.

MAVS

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Potency	Source
CHEMBL5653589	↓ inhibits	Mechanistic	392.68 nM (Kd)	ChEMBL
CHEMBL3752910	↓ inhibits	Mechanistic	5243.38 nM (Kd)	ChEMBL

MX1

UniProt Ensembl DGIdb Open Targets

Pipeline results not yet available for this target. Run the pipeline to populate.

OAS1

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Source
RIBAVIRIN	? unclear	Mechanistic	DGIdb
PEGINTERFERON ALFA-2A	? unclear	Mechanistic	DGIdb
PEGINTERFERON ALFA-2B	? unclear	Mechanistic	DGIdb

PDCD1

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Potency	Source
PEMBROLIZUMAB	↓ inhibits	Mechanistic		DGIdb
PUCOTENLIMAB	↓ inhibits	Mechanistic		DGIdb
TISLELIZUMAB	↓ inhibits	Mechanistic		DGIdb
EZABENLIMAB	? unclear	Mechanistic		DGIdb
ANTI-PD-1 MONOCLONAL ANTIBODY SYM021	? unclear	Mechanistic		DGIdb
AMP-224	? unclear	Mechanistic		DGIdb
SPARTALIZUMAB	↓ inhibits	Mechanistic		DGIdb
DOSTARLIMAB	↓ inhibits	Mechanistic		DGIdb
CEMIPLIMAB	↓ inhibits	Mechanistic		DGIdb
CT-011	? unclear	Mechanistic		DGIdb
LOMVASTOMIG	↓ inhibits	Mechanistic		DGIdb
PIDILIZUMAB	↓ inhibits	Mechanistic		DGIdb
CADONILIMAB	↓ inhibits	Mechanistic		DGIdb
CAMRELIZUMAB	↓ inhibits	Mechanistic		DGIdb
PENPULIMAB	↓ inhibits	Mechanistic		DGIdb
MEDI0680	? unclear	Mechanistic		DGIdb
FINOTONLIMAB	↓ inhibits	Mechanistic		DGIdb
CETRELIMAB	↓ inhibits	Mechanistic		DGIdb
SERPLULIMAB	↓ inhibits	Mechanistic		DGIdb
BUDIGALIMAB	↓ inhibits	Mechanistic		DGIdb
LIPUSTOBART	? unclear	Mechanistic		DGIdb
DURVALUMAB	? unclear	Mechanistic		DGIdb
BALSTILIMAB	↓ inhibits	Mechanistic		DGIdb
RETIFANLIMAB	↓ inhibits	Mechanistic		DGIdb
TEBOTELIMAB	↓ inhibits	Mechanistic		DGIdb
BINTRAFUSP ALFA	? unclear	Mechanistic		DGIdb
APL-501	↓ inhibits	Mechanistic		DGIdb
VUDALIMAB	? unclear	Mechanistic		DGIdb
AUNP-12	? unclear	Mechanistic		DGIdb
CS-1003	↓ inhibits	Mechanistic		DGIdb
ZIMBERELIMAB	↓ inhibits	Mechanistic		DGIdb
PIMIVALIMAB	↓ inhibits	Mechanistic		DGIdb
SINTILIMAB	↓ inhibits	Mechanistic		DGIdb
CC-90006	? unclear	Mechanistic		DGIdb
GEPTANOLIMAB	? unclear	Mechanistic		DGIdb
TORIPALIMAB	↓ inhibits	Mechanistic		DGIdb
NIVOLUMAB	↓ inhibits	Mechanistic		DGIdb
SASANLIMAB	↓ inhibits	Mechanistic		DGIdb
CHEMBL4436009	↓ inhibits	Mechanistic	3390.0 nM (Kd)	ChEMBL
CHEMBL4458745	↓ inhibits	Mechanistic	3140.0 nM (Kd)	ChEMBL

Showing top 40 of 44 agents ranked by evidence tier.

STAT1

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Source
CISPLATIN	? unclear	Mechanistic	DGIdb
CHEMBL:CHEMBL85826	? unclear	Mechanistic	DGIdb
PICOPLATIN	? unclear	Mechanistic	DGIdb
GUTTIFERONE K	? unclear	Mechanistic	DGIdb
IPRIFLAVONE	? unclear	Mechanistic	DGIdb
GARCINOL	? unclear	Mechanistic	DGIdb

TGFB1

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Potency	Source
INTERFERON ALFA-2B	? unclear	Mechanistic		DGIdb
PIOGLITAZONE HYDROCHLORIDE	? unclear	Mechanistic		DGIdb
SILYMARIN	? unclear	Mechanistic		DGIdb
RITUXIMAB	? unclear	Mechanistic		DGIdb
VERAPAMIL	? unclear	Mechanistic		DGIdb
PROTEASOME INHIBITOR	? unclear	Mechanistic		DGIdb
FRESOLIMUMAB	? unclear	Mechanistic		DGIdb
ATENOLOL	? unclear	Mechanistic		DGIdb
BINTRAFUSP ALFA	~ modulates	Mechanistic		DGIdb
NISEVOKITUG	? unclear	Mechanistic		DGIdb
LUSPATERCEPT	↓ inhibits	Mechanistic		DGIdb
TRETINOIN	? unclear	Mechanistic		DGIdb
HYDROCORTISONE BUTYRATE	? unclear	Mechanistic		DGIdb
VITAMIN E	? unclear	Mechanistic		DGIdb
IRINOTECAN HYDROCHLORIDE	? unclear	Mechanistic		DGIdb
INOSITOL	? unclear	Mechanistic		DGIdb
NICOTINE POLACRILEX	? unclear	Mechanistic		DGIdb
FENRETINIDE	? unclear	Mechanistic		DGIdb
MELATONIN	? unclear	Mechanistic		DGIdb
ISOTRETINOIN	? unclear	Mechanistic		DGIdb
VACTOSERTIB	? unclear	Mechanistic	12.9 nM (IC50)	DGIdb
TRIAMCINOLONE	? unclear	Mechanistic		DGIdb
TAMOXIFEN	? unclear	Mechanistic		DGIdb
ADRIAMYCIN	? unclear	Mechanistic		DGIdb
HEPARAN SULFATE	? unclear	Mechanistic		DGIdb
GOSSYPOL	? unclear	Mechanistic		DGIdb
TCDD	? unclear	Mechanistic		DGIdb
AMIFOSTINE ANHYDROUS	? unclear	Mechanistic		DGIdb
RAMIPRIL	? unclear	Mechanistic		DGIdb
ANTIOXIDANT	? unclear	Mechanistic		DGIdb
SOTATERCEPT	? unclear	Mechanistic		DGIdb
ASPIRIN	? unclear	Mechanistic		DGIdb
GALUNISERTIB	? unclear	Mechanistic		DGIdb
KEYHOLE LIMPET HEMOCYANIN	? unclear	Mechanistic		DGIdb
PIRFENIDONE	? unclear	Mechanistic		DGIdb
H2O2	? unclear	Mechanistic		DGIdb
THERAPEUTIC ANDROGEN	? unclear	Mechanistic		DGIdb
SANDOSTATIN	? unclear	Mechanistic		DGIdb
BROXURIDINE	? unclear	Mechanistic		DGIdb
DISITERTIDE	? unclear	Mechanistic		DGIdb

Showing top 40 of 62 agents ranked by evidence tier.

TLR3

UniProt Ensembl DGIdb Open Targets

Therapeutic Agent	Effect Direction	Evidence Tier	Potency	Source
POLY ICLC	? unclear	Mechanistic		DGIdb
POLY(I:C)	↑ activates	Mechanistic		DGIdb
BEVASIRANIB	↑ activates	Mechanistic		DGIdb
ASPIRIN	? unclear	Mechanistic		DGIdb
RINTATOLIMOD	↑ activates	Mechanistic		DGIdb
IL-4	? unclear	Mechanistic		DGIdb
IL-13	? unclear	Mechanistic		DGIdb
MEASLES VACCINE	? unclear	Mechanistic		DGIdb
BEVASIRANIB SODIUM	↑ activates	Mechanistic		DGIdb
HYDROXYCHLOROQUINE	? unclear	Mechanistic		DGIdb
CHEMBL4064228	↑ activates	Mechanistic	42500.0 nM (EC50)	ChEMBL
CHEMBL4074408	↑ activates	Mechanistic	4800.0 nM (EC50)	ChEMBL
CHEMBL4105063	↑ activates	Mechanistic	22300.0 nM (EC50)	ChEMBL
CHEMBL4636498	↓ inhibits	Mechanistic	5440.0 nM (IC50)	ChEMBL
CHEMBL4647818	↓ inhibits	Mechanistic	2160.0 nM (IC50)	ChEMBL
CHEMBL4795714	↓ inhibits	Mechanistic	2400.0 nM (IC50)	ChEMBL
CHEMBL19954	↓ inhibits	Mechanistic	110.0 nM (IC50)	ChEMBL
CHEMBL4303728	↓ inhibits	Mechanistic	3440.0 nM (IC50)	ChEMBL

Clinical Trials

Recruiting and recently completed trials from ClinicalTrials.gov. Data retrieved 2026-07-06.

No recent clinical trials found on ClinicalTrials.gov for this condition.

Agents Found By Disease-Level Search

Searched directly from “Hepatitis C” via ClinicalTrials.gov interventions and Open Targets' disease→drug data — independent of the 15-gene target panel above. This surfaces agents whose mechanism doesn't route through a curated gene (combination therapies, standard-of-care drugs, targets outside the panel).

60 agents shown (approved or with trial evidence) — 56 not found by the gene-target search above.

Ribavirin

· 8 trials · source: ClinicalTrials.gov
NCT01833533 NCT02786537 NCT00484328

Peginterferon alfa-2b (SCH 54031)NOT in gene-target list

· 5 trials · source: ClinicalTrials.gov
NCT00723931 NCT00705666 NCT00302081

pegylated interferon alpha 2a and ribavirinNOT in gene-target list

· 3 trials · source: ClinicalTrials.gov
NCT00540345 NCT00540345 NCT00629967

DanoprevirNOT in gene-target list

· 3 trials · source: ClinicalTrials.gov
NCT01220947 NCT01220947 NCT01220947

BMS-790052NOT in gene-target list

· 3 trials · source: ClinicalTrials.gov
NCT01051414 NCT01016912 NCT01016912

Peginterferon alfa-2a

· 3 trials · source: ClinicalTrials.gov
NCT00006164 NCT00491244 NCT01853254

ribavirin (SCH 18908)NOT in gene-target list

· 3 trials · source: ClinicalTrials.gov
NCT00302081 NCT00302081 NCT00705666

PegIntron (peginterferon alfa-2b; SCH 54031)NOT in gene-target list

· 3 trials · source: ClinicalTrials.gov
NCT00724854 NCT00081770 NCT00081770

Pegylated interferon alfa-2a and ribavirinNOT in gene-target list

· 2 trials · source: ClinicalTrials.gov
NCT00540345 NCT00629967

Ritonavir

· 2 trials · source: ClinicalTrials.gov
NCT01220947 NCT01323257

Sofosbuvir/Velpatasvir

· 2 trials · source: ClinicalTrials.gov
NCT03057847 NCT03809533

erythromycinNOT in gene-target list

· 2 trials · source: ClinicalTrials.gov
NCT01323257 NCT01323257

TMC435NOT in gene-target list

· 2 trials · source: ClinicalTrials.gov
NCT01323257 NCT01323257

BI 201335 NA 120 mg capsuleNOT in gene-target list

· 2 trials · source: ClinicalTrials.gov
NCT01704846 NCT01704846

BI 201335 NA 40 mg capsuleNOT in gene-target list

· 2 trials · source: ClinicalTrials.gov
NCT01704846 NCT01704846

Peginterferon alfa-2a [Pegasys]NOT in gene-target list

· 2 trials · source: ClinicalTrials.gov
NCT01066819 NCT00475072

Rebetol (ribavirin; SCH 18908)NOT in gene-target list

· 2 trials · source: ClinicalTrials.gov
NCT00724854 NCT00081770

pegylated interferon alpha 2a, ribavirinNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT02377856

pegylated interferon alpha 2a and plus ribavirinNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00540345

VitaliverNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00562783

Telaprevir; EscitalopramNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00933894

CP 675,206NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01008358

CopegusNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01220947

PegasysNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01220947

ABT-450/r/ABT-267, ABT-333NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01833533

Placebo for RibavirinNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01833533

BMS-650032NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01051414

Computer-assisted counselingNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT02752152

On-demand counselingNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT02752152

Standard counselingNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT02752152

Appointment + reminderNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT02752152

ReminderNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT02752152

No appointment and no reminderNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT02752152

Peginterferon alfa-2a + RibavirinNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00006164

Glecaprevir/PibrentasvirNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT03235349

FK788NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00047814

Daclatasvir, Asunaprevir and BMS-791325 FDCNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT02104843

BMS-791325NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT02104843

RosuvastatinNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT02104843

Peginterferon alfa-2a and ribavirinNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00491244

VX-950NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00251199

peginterferonNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00251199

DarunavirNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01323257

Citalopram or PlaceboNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00108563

Pegylated-Interferon Alfa 2b (PEG-IFN)NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01482767

Ribavirin (RBV)NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01482767

Boceprevir (BOC)NOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01482767

PegIntronNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00709228

RebetolNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT00709228

AutoinjectorNOT in gene-target list

· 1 trial · source: ClinicalTrials.gov
NCT01087944